Solid Biosciences, Inc. (SLDB)
6.92
-0.14
(-1.98%)
USD |
NASDAQ |
Oct 06, 16:00
6.91
-0.01
(-0.14%)
After-Hours: 20:00
Solid Biosciences Price to Book Value : 1.945 for Oct. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 1.945 |
| October 05, 2026 | 1.984 |
| October 02, 2026 | 1.925 |
| October 01, 2026 | 1.962 |
| September 30, 2026 | 2.032 |
| September 29, 2026 | 2.012 |
| September 28, 2026 | 2.046 |
| September 25, 2026 | 2.049 |
| September 24, 2026 | 2.102 |
| September 23, 2026 | 2.254 |
| September 22, 2026 | 2.507 |
| September 21, 2026 | 2.40 |
| September 18, 2026 | 2.504 |
| September 17, 2026 | 2.493 |
| September 16, 2026 | 2.451 |
| September 15, 2026 | 2.352 |
| September 14, 2026 | 2.456 |
| September 11, 2026 | 2.445 |
| September 10, 2026 | 2.549 |
| September 09, 2026 | 2.681 |
| September 08, 2026 | 2.791 |
| September 04, 2026 | 2.880 |
| September 03, 2026 | 2.928 |
| September 02, 2026 | 2.890 |
| September 01, 2026 | 2.777 |
| Date | Value |
|---|---|
| August 31, 2026 | 2.692 |
| August 28, 2026 | 2.746 |
| August 27, 2026 | 2.847 |
| August 26, 2026 | 2.732 |
| August 25, 2026 | 2.779 |
| August 24, 2026 | 2.574 |
| August 21, 2026 | 2.614 |
| August 20, 2026 | 2.557 |
| August 19, 2026 | 2.737 |
| August 18, 2026 | 2.552 |
| August 17, 2026 | 2.557 |
| August 14, 2026 | 2.586 |
| August 13, 2026 | 2.552 |
| August 12, 2026 | 2.548 |
| August 11, 2026 | 2.487 |
| August 10, 2026 | 2.406 |
| August 07, 2026 | 2.358 |
| August 06, 2026 | 2.448 |
| August 05, 2026 | 2.453 |
| August 04, 2026 | 2.422 |
| August 03, 2026 | 2.254 |
| July 31, 2026 | 2.265 |
| July 30, 2026 | 2.386 |
| July 29, 2026 | 2.260 |
| July 28, 2026 | 2.240 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 18.62 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.248 |
| Curis, Inc. | 0.3109 |
Price to Book Value Related Metrics
| Price | 6.92 |
| Earnings Yield | -27.58% |
| Market Cap | 727.47M |